Editorial: The Treatment of RAS or BRAF Mutated Metastatic Colorectal Cancer: Challenges and Perspectives

被引：1
|
作者：
Ottaiano, Alessandro [1 ]
Berretta, Massimiliano [2 ]
Von Arx, Claudia [1 ]
Capozzi, Monica [1 ]
Caraglia, Michele [3 ]
机构：
[1] Ist Ric & Cura Carattere Sci IRCCS G Pascale, Ist Nazl Tumori Napoli, Naples, Italy
[2] Univ Messina, Dept Clin & Expt Med, Messina, Italy
[3] Univ Campania L Vanvitelli, Dept Precis Med, Naples, Italy
来源：
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词：
colorectal cancer; KRAS; BRAF; prognosis; therapy;
D O I：
10.3389/fonc.2022.852445
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives
    Sanz-Garcia, E.
    Argiles, G.
    Elez, E.
    Tabernero, J.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2648 - 2657
  • [42] BRAF Inhibitors in BRAF-Mutated Colorectal Cancer: A Systematic Review
    Aiman, Wajeeha
    Ali, Muhammad Ashar
    Jumean, Samer
    Asfeen, Ummul
    Garcia, Jose
    Quirem, Murad
    Ahmad, Amaar
    Rayad, Mohammad Nabil
    Alkhlaifat, Osama
    Al Omour, Bader
    Chemarthi, Venkata S.
    Maroules, Michael
    Guron, Gunwant
    Shaaban, Hamid
    Suzuki, Hidekazu
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [43] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
    Li, Zi-Nan
    Zhao, Lin
    Yu, Li-Feng
    Wei, Min-Jie
    GASTROENTEROLOGY REPORT, 2020, 8 (03): : 192 - 205
  • [44] Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis
    Zlobec, Inti
    Bihl, Michel P.
    Schwarb, Heike
    Terracciano, Luigi
    Lugli, Alessandro
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (02) : 367 - 380
  • [45] Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer
    Akhoundova, Dilara
    Pietge, Heike
    Hussung, Saskia
    Kiessling, Michael
    Britschgi, Christian
    Zoche, Martin
    Rechsteiner, Markus
    Weber, Achim
    Fritsch, Ralph M.
    JCO PRECISION ONCOLOGY, 2021, 5 : 1082 - 1087
  • [46] Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer
    Kopetz, Scott
    Desai, Jayesh
    Chan, Emily
    Hecht, Joel Randolph
    O'Dwyer, Peter J.
    Maru, Dipen
    Van Morris
    Janku, Filip
    Dasari, Arvind
    Chung, Woonbook
    Issa, Jean-Pierre J.
    Gibbs, Peter
    James, Brian
    Powis, Garth
    Nolop, Keith B.
    Bhattacharya, Suman
    Saltz, Leonard
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (34) : 4032 - 4038
  • [47] Age-associated mutations in RAS-mutated versus RAS-nonmutated metastatic colorectal cancer
    Kundranda, Madappa N.
    Kemkes, Ariane C.
    Routh, Josh
    Jean-Paul, De La O.
    Evans, Mark C.
    Flannery, Cynthia A.
    Hall, David W.
    Therala, Nishitha
    Turner, Michelle
    Thakkar, Snehal Govind
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [48] Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations
    Voutsadakis, Ioannis A.
    PHARMACOGENOMICS, 2025,
  • [49] Immunotherapy of Metastatic Colorectal Cancer: Prevailing Challenges and New Perspectives
    Zumwalt, Timothy J.
    Goel, Ajay
    CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (03) : 125 - 140
  • [50] Association of RAS/BRAF Status and Prognosis of Metastatic Colorectal Cancer: Analysis of 1002 Consecutive Cases
    Tang, Wentao
    Liu, Yu
    Ji, Meiling
    Liu, Tianyu
    Chen, Yijiao
    Zhuang, Aobo
    Mao, Yihao
    Chang, Wenju
    Wei, Ye
    Ren, Li
    Xu, Jianmin
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (06) : 3593 - 3603
12345